Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice

BACKGROUND: SARS-CoV-2 has caused a global pandemic, infecting millions of people. A safe, effective vaccine is urgently needed and remains a global health priority. Subunit vaccines are used successfully against other viruses when administered in the presence of an effective adjuvant. METHODS: We e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wørzner, Katharina, Sheward, Daniel J., Schmidt, Signe Tandrup, Hanke, Leo, Zimmermann, Julie, McInerney, Gerald, Hedestam, Gunilla B. Karlsson, Murrell, Ben, Christensen, Dennis, Pedersen, Gabriel Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808923/
https://www.ncbi.nlm.nih.gov/pubmed/33422991
http://dx.doi.org/10.1016/j.ebiom.2020.103197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808923/
https://www.ncbi.nlm.nih.gov/pubmed/33422991
http://dx.doi.org/10.1016/j.ebiom.2020.103197

Ejemplares similares